AIm: Lung cancer is the leading cause of cancer-related mortality worldwide. Pain is a common problem in these patients, yet inadequate or dissatisfactory management is prevalent. mAterIAl and methOds: Between 1987 and 2012, 224 patients with intractable pain were treated with computerized tomography (CT)-guided cordotomy. Among them, 210 had intractable pain due to malignancies. The majority of the cases were diagnosed as pulmonary malignancies (108 patients). Sixty-seven were pulmonary carcinoma, 26 mesothelioma and 15 Pancoast tumors. results: After cordotomy, 98.13% of cancer patients reported initial pain relief. Minimum and maximum preoperative scores of the Karnofsky Performance Scale were 20 and 70, versus postoperative scores of 40 and 90 (p<0.001). The median preoperative VAS score was 8 (6-9). On the first postoperative day, the score dropped sharply to 0 (0-8) (p<0.001). In this selected series of 108 percutaneous cordotomy procedures, as well as in the total series of 224 patients, there was no mortality or major morbidity.
INTRODUCTION
Cancer and cancer-related disorders remain significant public health problems. Cancer incidence continues to be on the rise due to the increase in the average lifespan, growth of the population and changing environmental conditions worldwide. Despite the unquestioned benefits of economic development and the rapid advances in technology, as they concern health, their invasion into nearly every aspect of our daily lives is reflected negatively in our sedentary lifestyle, unhealthy nutritional habits and exposure to air pollution, all of which may be cancer-causing factors.
Lung cancer is the leading cause of cancer-related mortality worldwide (16) . Approximately 1.6 million new lung cancer cases are diagnosed in the world each year, about 220,000 of
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which are diagnosed in the United States (1, 17) . The lung is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths (15) .
Early detection is the major goal, but only 15% of lung cancer is diagnosed in the early stage. The 5-year survival rate for all stages combined is only 16% (1) . Substantial numbers of patients diagnosed with localized disease are often unsuitable for curative surgical procedures due to concomitant medical illness (32). The prognosis remains unsatisfactory, and the development of new therapeutic strategies is still an urgent demand (2) .
Serious problems like pain, fatigue, insomnia, and mood disturbance due to cancer or to the treatment itself increase the burden of the case and further complicate management of the disease. The available literature underlines the fact that these four symptoms may occur in a cluster and negatively influence a patient's life quality during cancer therapy; thus, there is a need to evaluate effective interventions to solve them (5,34).
Studies confirm that adults with lung cancer have more symptoms than patients with other types of cancer (8) . Pain is a common problem in these patients, such that approximately 75% of those with advanced stage cancer experience pain, yet inadequate or dissatisfactory management is prevalent (12, 24) . Despite the high prevalence of cancer-related pain and the associated disability, it is frequently undertreated (4, 6, 7, 10, 30, 35) .
Pain may be caused by the progression of the tumor or the treatment itself, including surgery, chemotherapy and radiation. Pain may cause decreased activity, anorexia and sleep deprivation, all of which weaken patients in their fight against cancer. This paper was prepared with the aim of stressing that pain management in cancer patients, especially those with lung cancer, is as important as the cancer treatment itself. Although developing technologies, cordotomy technique is still not widely used for control of cancer pain all over the world (33). Appropriate pain management can provide an acceptable quality of life for the patient and facilitate compliance with the primary treatment.
PATIENTS and METHODS
Between 1987 and 2012, 224 patients with intractable pain were treated by only one surgeon by computerized tomography (CT)-guided cordotomy in the Department of Neurosurgery, Ankara University and in the private practice of the senior author. Among the 224 patients in the series, 210 had intractable pain due to malignancies. The majority of the cases were diagnosed as pulmonary malignancies (108 patients). Of the 108 admitted for treatment of intractable pain, 67 were pulmonary carcinoma, 26 mesothelioma and 15 Pancoast tumors.
Cordotomy is based on the lesioning of the lateral spinothalamic tract in the anterolateral spinal cord, which transmits the pain sensation ( Figure 1 ). The procedure is preferred especially in nociceptive intractable pain problems in malignancy (21). Since 1987, cordotomy has been performed using special needle electrodes with the help of CT imaging (19). Most intractable pain in cancer patients is nociceptive at the onset, caused by nerve irritation. Over time, the nociceptive pain progresses to neuropathic pain due to neural damage, and this type of pain is continuous. As defined by the patients, the sensations are burning and throbbing (36) .
A visual analogue scale (VAS) was used to score the severity of the pain, and the Karnofsky performance scale was used to determine the performance status of the patients on the first postoperative day. Post-cordotomy, the pain measurement scale was determined as follows: I -no pain, II -partial satisfactory pain relief, III -partial non-satisfactory pain relief, and IV -no change in pain. In this grading system, grade I and II patients were considered as having pain relief and grade III and IV considered as failing in obtaining the desired pain relief after surgical intervention.
The Wilcoxon signed rank test was used to test the differences between pre-and postoperative VAS and Karnofsky Performance Scale scores. SPSS for Windows (Version 17.0; SPSS, Inc.) was used for statistical analysis. A P value of less than 0.05 was considered significant.
CT-GUIDED PERCUTANEOUS CORDOTOMY TECHNIQUE
The target in cordotomy is the lateral spinothalamic tract located in the anterolateral part of the spinal cord (14, 40) . This ascending tract carries information chiefly about pain and temperature and relays some tactile information ( Figure 1 ). The organization of fibers from the outside inward reflects superficial pain, temperature and deep pain, respectively (36) . Because most fibers in the anterolateral system decussate over two to five segments before entering the anterolateral columns, spinothalamic cordotomy aims to interrupt the spinothalamic tract ascending contralaterally to the painful side (40) .
The anterolateral sensory system has a somatotopic relationship, with fibers from higher levels laminating medially and ventrally and fibers from lower levels laminating laterally and dorsally within the lateral spinothalamic tract (14, 36) . Segmentation of the fibers provides the opportunity for selective cordotomy, given that anteromedial lesions denervate the contralateral arm and upper chest region, while posterolateral lesions denervate the sacral and lumbar areas ( Figure 1 ) (21).
The percutaneous cordotomy operation is principally based on the lesioning of the lateral spinothalamic tract, which carries pain and temperature sensations, at the C1-C2 level ( Figures  2A,B, 3, 4A ,B). The procedure is performed contralaterally to the pain side. The best candidates are those with unilateral localized intractable nociceptive-type somatic cancer pain, as seen in mesothelioma of the chest wall or malignancy of the lower extremities and those with unilateral localized pain problems (18,20). Secondary candidates are patients with nociceptive pain at the onset of the disease, but in whom the pain may evolve to neuropathic form if the tumor infiltrates the brachial plexus, as in Pancoast tumors. These patients are accepted as candidates for cordotomy. Patients suffering from pure neuropathic pain were not considered as candidates for cordotomy in our series because the procedure is not effective in neuropathic pain (20).
An important point that needs to be stressed is that in some cases of Pancoast tumors, the problem starts as nociceptive pain. Later, the clinical picture turns to the infiltration of the plexus and causes neuropathic pain. This situation must be explained to the patient. Patients with severe pulmonary dysfunction in whom partial oxygen saturation is lower than 80% are also not suitable candidates for cordotomy. If heavy pleural effusion is present, we suggest its drainage preoperatively, but if it persists, it is recommended to 
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The series included 85 males (78.7%) and 23 females (21.3%), with a mean age of 53.8 (±10.4) years. The majority of cases were attributable to pulmonary carcinoma (n=67), followed by mesothelioma (n=26) and Pancoast tumors (n=15).
After cordotomy, 98.13% of patients reported pain relief (Grade I, 88.88%; Grade II, 9.25%; Grade III, 1.85%; Grade IV, 0.0%). The median preoperative VAS score was 8 (6-9). On the first postoperative day, the score dropped sharply to 0 (0-8) (p<0.001). The Karnofsky Performance Scale was used immediately pre-and postoperatively as a measure of change in patient performance. Minimum and maximum preoperative scores were 20 and 70, versus postoperative scores of 40 and 90, and the difference was determined to be highly significant (p<0.001). Median (minimum -maximum) Karnofsky Performance Scale and VAS scores of the cordotomy procedures in total are summarized in Table I .
The results of cordotomy procedures divided according to the specific lung cancer types are summarized in Table II . The differences in each group pre-and postoperatively were determined to be highly significant (p≤0.001).
Complications were prevented by avoiding incorrect localization with direct imaging guidance with CT scanning and by avoiding creation of large lesions by using thinner electrodes, e.g., the Kanpolat Computed Tomography Electrode.
In this selected series of 108 percutaneous cordotomy procedures, as well as in the total series of 224 patients, there was no mortality or major morbidity (20,21,22,23). Dysesthesia was seen in 4 patients (1.78%, one with Pulmonary Carcinoma, one with Pancoast tumor, one with mesothelioma and the other with Malignant Melanoma) and accepted as a real complication after the procedure. Motor weakness was seen in one patient but considered as a transient complication and disappeared within about 2 weeks postoperatively.
DISCUSSION
Lung cancer and especially the pain it causes are socialhumanitarian problems in addition to their burden as healthcare problems. The International Association for the Study of Pain (IASP) has recognized pain relief as a human right (3). Patients with cancer differ from others in their necessity for a better life quality and for prevention, to the extent possible, of the associated symptoms that may develop as a result of the primary treatment. Pain, fatigue, insomnia, anorexia, and constipation are among the primary and most frequent of the many problems occurring secondary to cancer and its treatment, and they must be managed appropriately (5).
delay the procedure and consult with the Department of Pulmonary Diseases. The cordotomy procedure should be considered carefully if the patient is receiving chemotherapy or radiotherapy for cancer. Detailed information about the procedure and the expectations from the procedure should be clearly explained to both the patient and family (20).
RESULTS
Between 1987 and 2012, a special segment of cancer patients with lung cancer were treated with CT-guided percutaneous cordotomy. This group is the largest cancer patient group in our practice. Intractable pain due to lung cancer was treated in 108 patients from 1987-2012 without any mortality or important morbidity. 
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In addition to the observed side effects of opioids like constipation and nausea, against which no tolerance develops, physical dependence, tolerance, breath depression, hyperalgesia, and immunologic dysfunction may occur. Recent studies have shown that neural plasticity associated with the development of opioid tolerance may activate a pronociceptive mechanism that could counteract the analgesic effects of opioids (26).
Gybels suggests that selected patients for the classic cordotomy procedure should be assumed to have at least 2-5 months of survival (13) . However, according to our series and the result of procedures in approximately 250 patients, unless the patient is in agony, we believe that cordotomy is effective and has to be chosen in all cancer patients even if they have only a few weeks of survival.
In general, physicians and the relatives of cancer patients are afraid of applying invasive risky procedures in terminally ill patients. Contrary to this approach, and also according to the feedback of our patients, CT-guided percutaneous cordotomy should be considered as a good option. Most of the patients in our series insisted on having the procedure applied, whatever the risks. It is important to ask "why?". Cancer patients suffering from pain dream of being able to sleep more than one hour continuously per day, eat whatever they want, return to an active life, and socialize with their friends, etc.
The cancer patient has more than just the cancer disease! It is crucial to recognize this reality and to provide whatever is needed for these short-survival cases. Molecular and other studies are important and may be promising for the improvement of survival in cancer cases, but these are meaningless for the patient if other necessities are forgotten.
CT-guided percutaneous cordotomy is an effective procedure that should be used in the treatment of cancer-related pain problems. The safety of the procedure depends on correct patient selection and the experience of the surgeon. We suggest that cordotomy should be preferred as soon as possible in patients who fail to respond to the classic analgesic therapy.
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The American Pain Society calls attention to the five important areas in the management of pain. It is recommended: to recognize and treat pain promptly; involve the patients and families in the pain-management plan; improve treatment patterns by eliminating inappropriate practices and providing multimodal therapy; and reassess and adjust the pain management plan as needed (28).
In this science and technology age in which we live, the following question is worth considering: 'What solutions can we offer oncological patients for their pain problems?' If science cannot provide even a painless death, this is a serious problem requiring immediate attention. The question to ask is whether to wait till the terminal stage to do something for pain or not. It is extremely important to consider persistent pain as a humanity problem beside being a health problem.
There is no doubt that an effective means of pain management in cancer patients is needed immediately. This is a social necessity. Some of our patients, with their primary disease under control, were able to return to their normal active life immediately after the cordotomy procedure.
The long-term follow-up of the patients in our series is inadequate. Nevertheless, the current results and outcomes of the procedure indicate that cordotomy is effective for intractable lung cancer pain, especially in mesothelioma (22).
Pain management practice needs to be basic but also effective. Making the patient dependent on physicians or the healthcare system is a cause of disability in the conduct of daily life (18). The patient's confidence regarding the method of pain treatment is very important for its success and over the disease course. The literature emphasizes that patients are reluctant to report their pain as a side effect, for fear of distracting the physicians from treating the cancer and due to their belief that pain is indicative of progressive disease (11, 27, 29, 31, 37, 38, 39) .
Some of our patients and their relatives have suggested that the cordotomy procedure be implemented worldwide and that physicians be encouraged in its use. We believe and suggest that cordotomy is the best solution for intractable pain problems in some patients suffering from lung cancer. This is the art of choosing the best procedure for the patient. We suggest that patients should be examined and followed by the same expert. Changing the physician over the treatment course will negatively affect the success of the process.
Opioid agents are primarily used to provide analgesia in cancer patients. However, they may be inadequate for pain palliation, or the therapy may be stopped because of the severe side effects or due to misuse. In Denmark, where opioids are prescribed liberally for chronic pain, Eriksen et al. reported worse pain, higher healthcare utilization and lower activity levels in opioid-treated patients compared to a matched cohort study of chronic pain patients not using opioids, suggesting that when opioids are prescribed liberally, even if some patients benefit, the overall population does not (9,25). 
